Prudential Financial Inc Denali Therapeutics Inc. Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 16,938 shares of DNLI stock, worth $290,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,938

Previous 16,878 0.36%

Holding current value

$290,486

Previous $236,000 3.81%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$12.75 - $15.65 $765 - $939	60 Added 0.36%	16,938 $245,000
Q2 2025 Aug 12, 2025	SELL	$11.47 - $16.65 $249,644 - $362,387	-21,765 Reduced 56.32%	16,878 $236,000
Q1 2025 May 13, 2025	SELL	$13.6 - $23.59 $978,520 - $1.7 Million	-71,950 Reduced 65.06%	38,643 $525,000
Q4 2024 Feb 11, 2025	SELL	$20.24 - $31.58 $137,632 - $214,744	-6,800 Reduced 5.79%	110,593 $2.25 Million
Q3 2024 Nov 13, 2024	BUY	$20.96 - $31.05 $13,624 - $20,182	650 Added 0.56%	117,393 $3.42 Million
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $543,257 - $843,211	36,314 Added 45.15%	116,743 $2.71 Million
Q1 2024 May 14, 2024	SELL	$15.83 - $23.35 $12,901 - $19,030	-815 Reduced 1.0%	80,429 $1.65 Million
Q4 2023 Feb 13, 2024	SELL	$16.2 - $23.18 $1.18 Million - $1.68 Million	-72,584 Reduced 47.19%	81,244 $1.74 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $608,708 - $890,196	29,506 Added 23.73%	153,828 $3.17 Million
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $2.69 Million - $3.8 Million	115,142 Added 1254.27%	124,322 $3.67 Million
Q1 2023 May 12, 2023	SELL	$21.91 - $32.67 $131 - $196	-6 Reduced 0.07%	9,180 $211,000
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $23,573 - $30,426	897 Added 10.82%	9,186 $0
Q3 2022 Nov 04, 2022	BUY	$25.97 - $38.53 $1,402 - $2,080	54 Added 0.66%	8,289 $243,000
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $261,375 - $440,508	-12,518 Reduced 60.32%	8,235 $238,000
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $5.66 Million - $9.22 Million	-195,048 Reduced 90.38%	20,753 $667,000
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $1.21 Million - $1.56 Million	28,339 Added 15.12%	215,801 $9.71 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $1.58 Million - $2.55 Million	-32,552 Reduced 14.8%	187,462 $9.46 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $1.61 Million - $2.52 Million	32,070 Added 17.06%	220,014 $17.3 Million
Q1 2021 May 12, 2021	BUY	$53.8 - $81.53 $5.28 Million - $8.01 Million	98,225 Added 109.48%	187,944 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $2.06 Million - $5.23 Million	55,914 Added 165.4%	89,719 $7.52 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $781,909 - $1.31 Million	33,805 New	33,805 $1.21 Million

Others Institutions Holding DNLI

# of Institutions

263

Shares Held

128M

Call Options Held

227K

Put Options Held

122K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.3B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Denali Therapeutics Inc. Transaction History